BACKGROUNDPemphigus foliaceus and pemphigus vulgaris are endemic in the northeastern region
of São Paulo State, Brazil. They are treated mainly with systemic corticosteroids,
which may provoke osteoporosis; atherosclerosis, higher blood pressure, insulin
resistance, glucose intolerance, hyperlipidemia and abdominal obesity. These side
effects of corticoids also constitute criteria for the diagnosis of metabolic
syndrome.OBJECTIVEThe prevalence of metabolic syndrome and each component of metabolic syndrome in
Pemphigus foliaceus and pemphigus vulgaris groups was compared with Brazilian
casuistic samples.METHODSData of 147 patients (pemphigus foliaceus 48.9% and pemphigus vulgaris 51.1%) were
compiled from medical records regarding metabolic syndrome and its components, and
included in the analysis.RESULTSThere was no significant difference regarding the prevalence of metabolic syndrome
in pemphigus groups compared with the Brazilian casuistic samples. The analysis of
each component of metabolic syndrome showed a higher prevalence of: higher blood
pressure in male subjects with pemphigus vulgaris, and in pemphigus foliaceus in
both genders; diabetes mellitus in both genders for pemphigus vulgaris and
pemphigus foliaceus; obesity in females for pemphigus vulgaris and pemphigus
foliaceus, and hypertriglyceridemia in both genders for pemphigus vulgaris and
pemphigus foliaceus groups that were statistically significant compared to the
Brazilian reports. Furthermore, the study noted a higher incidence of
cardiovascular events in both genders in pemphigus foliaceus and pemphigus
vulgaris groups than in Brazilian casuistic samples.CONCLUSIONThe components of metabolic syndrome are more numerous in pemphigus when compared
with Brazilian casuistic samples. Future studies are necessary to assure that
metabolic syndrome may be associated with pemphigus per se, including a greater
casuistic sample of patients who have not taken corticoids.